Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma

Abroad (travel likely)Recruiting

Conditions

Soft Tissue Sarcoma · Stage I Soft Tissue Sarcoma of the Trunk and Extremities · Stage II Soft Tissue Sarcoma of the Trunk and Extremities · Stage III Soft Tissue Sarcoma of the Trunk and Extremities

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Contact: Study coordinator (Clinical Trial Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Krista A. Goulding, MD, MPH)

Study leads

Krista A. Goulding, MD, MPH
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Pediatric Solid Tumor · Osteosarcoma · Rhabdomyosarcoma

Abroad (travel likely)RecruitingPHASE1

Memphis, United States

Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas

Osteosarcoma · Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE2

Hanzhong, China

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma · Sarcoma,Soft Tissue · Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States